News

CURE5d
Tracing a Five-Generation Cancer Legacy Through Genetic Discovery
I want my family to understand our shared cancer risks, but I sometimes struggle to face the painful reality of the disease ...
The Manila Times6d
Candel Therapeutics Receives FDA Regenerative Medicine Advanced Therapy Designation for CAN-2409 for the Treatment of Prostate Cancer
Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on ...
Mirage News3d
Pfizer Combo Halves Death Risk in BRAF V600E Cancer
Pfizer Inc. (NYSE: PFE) today announced statistically significant and clinically meaningful survival results from the Phase 3 ...
Using AI to detect changes in lung tumors with greater speed and precision
More and more thoracic CT scans are being performed worldwide in order to detect lung diseases such as bronchial carcinoma ...
ascopubs.org5d
HERTHENA-Lung01, a Phase II Trial of Patritumab Deruxtecan (HER3-DXd) in Epidermal Growth Factor Receptor–Mutated Non–Small-Cell Lung Cancer After Epidermal Growth Factor ...
patients with previous or current evidence of interstitial lung disease (ILD) were excluded. An Eastern Cooperative Oncology Group performance status of 0 or 1 was required at screening. Patients ...
ascopubs.org6d
Phase 1 study of AMG 119, a chimeric antigen receptor (CAR) T cell therapy targeting DLL3, in patients with relapsed/refractory small cell lung cancer (SCLC).
Phase 2 trial of first-line pembrolizumab with platinum doublet chemotherapy and radiotherapy in patients (pts) with unresectable, locally advanced stage III non–small-cell lung cancer (NSCLC): ...